{
  "ticker": "CRL",
  "year": 2023,
  "quarter": 1,
  "last_updated": "2025-04-15T14:53:27.739286",
  "count": 39,
  "transactions": [
    {
      "id": 46448,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-03-07",
      "transaction_shares": "475",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "40255"
    },
    {
      "id": 80763,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-03-07",
      "transaction_shares": "475",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "40255"
    },
    {
      "id": 46465,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-23",
      "transaction_shares": "1750",
      "transaction_price": "220.73",
      "transaction_type": "P",
      "shares_after_transaction": "21864"
    },
    {
      "id": 80789,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "WALLMAN RICHARD F",
      "reporting_owner_cik": "0001198092",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-23",
      "transaction_shares": "1750",
      "transaction_price": "220.73",
      "transaction_type": "P",
      "shares_after_transaction": "21864"
    },
    {
      "id": 46438,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-02-22",
      "transaction_shares": "317",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "25330"
    },
    {
      "id": 46442,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "287",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "8476"
    },
    {
      "id": 46445,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "1814",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "214780"
    },
    {
      "id": 46454,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "308",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "40730"
    },
    {
      "id": 46460,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-02-22",
      "transaction_shares": "51",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "7838"
    },
    {
      "id": 46466,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-02-22",
      "transaction_shares": "136",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "5874"
    },
    {
      "id": 80749,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-02-22",
      "transaction_shares": "317",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "25330"
    },
    {
      "id": 80755,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "287",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "8476"
    },
    {
      "id": 80759,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "1814",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "214780"
    },
    {
      "id": 80774,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "308",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "40730"
    },
    {
      "id": 80780,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-02-22",
      "transaction_shares": "51",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "7838"
    },
    {
      "id": 80790,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-02-22",
      "transaction_shares": "136",
      "transaction_price": "243.60",
      "transaction_type": "F",
      "shares_after_transaction": "5874"
    },
    {
      "id": 46428,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-02-16",
      "transaction_shares": "3205",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "44243"
    },
    {
      "id": 46449,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-02-16",
      "transaction_shares": "4558",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "10568"
    },
    {
      "id": 80734,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-02-16",
      "transaction_shares": "3205",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "44243"
    },
    {
      "id": 80764,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-02-16",
      "transaction_shares": "4558",
      "transaction_price": "109.34",
      "transaction_type": "M",
      "shares_after_transaction": "10568"
    },
    {
      "id": 46456,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-02-15",
      "transaction_shares": "19892",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "216702"
    },
    {
      "id": 80776,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-02-15",
      "transaction_shares": "19892",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "216702"
    },
    {
      "id": 46455,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2023-02-01",
      "transaction_shares": "343",
      "transaction_price": "248.21",
      "transaction_type": "F",
      "shares_after_transaction": "15153"
    },
    {
      "id": 80775,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2023-02-01",
      "transaction_shares": "343",
      "transaction_price": "248.21",
      "transaction_type": "F",
      "shares_after_transaction": "15153"
    },
    {
      "id": 46436,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2023-01-27",
      "transaction_shares": "7229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18188"
    },
    {
      "id": 46437,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-01-27",
      "transaction_shares": "2096",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8534"
    },
    {
      "id": 46439,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-01-27",
      "transaction_shares": "8435",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "44191"
    },
    {
      "id": 46441,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2023-01-27",
      "transaction_shares": "7857",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11660"
    },
    {
      "id": 46447,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-01-27",
      "transaction_shares": "4820",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7319"
    },
    {
      "id": 46468,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-01-27",
      "transaction_shares": "8676",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "28908"
    },
    {
      "id": 80747,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2023-01-27",
      "transaction_shares": "7229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18188"
    },
    {
      "id": 80748,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2023-01-27",
      "transaction_shares": "2096",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8534"
    },
    {
      "id": 80751,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2023-01-27",
      "transaction_shares": "8435",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "44191"
    },
    {
      "id": 80754,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2023-01-27",
      "transaction_shares": "7857",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11660"
    },
    {
      "id": 80762,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2023-01-27",
      "transaction_shares": "4820",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7319"
    },
    {
      "id": 80794,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-01-27",
      "transaction_shares": "8676",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "28908"
    },
    {
      "id": 24152,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "244",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "244"
    },
    {
      "id": 46467,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "244",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "244"
    },
    {
      "id": 80793,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "244",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "244"
    }
  ]
}